Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | CCR1 | P32246 | 1/20 | 0.56 |
| ▸ | CCR5 | P51681 | 1/20 | 0.56 |
| ▸ | CCR8 | P51685 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | CASP3 | P42574 | 3/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12277217 | 0.89 | RXFP1 (0.55) | RXFP1NPC1RAB9ACASP3SENP7 | |
| SCHEMBL17754087 | 0.89 | RXFP1 (0.54) | RXFP1CCR1CCR5CCR8HDAC6 | |
| SCHEMBL11129508 | 0.86 | ACHE (0.60) | RXFP1NPC1RAB9ACASP3SENP7 | |
| SCHEMBL17051514 | 0.85 | CCR1 (0.75) | RXFP1CCR1CCR5CCR8HDAC6 | |
| SCHEMBL16656143 | 0.84 | CCR1 (0.67) | RXFP1CCR1CCR5CCR8HDAC6 | |
| SCHEMBL3716990 | 0.84 | RXFP1 (0.62) | RXFP1NPC1RAB9ACASP3SENP7 | |
| SCHEMBL2477927 | 0.83 | CCR1 (0.71) | CCR1CCR5CCR8HDAC6NPC1 | |
| SCHEMBL22454022 | 0.83 | NPC1 (0.56) | CCR1CCR5CCR8HDAC6NPC1 | |
| SCHEMBL12393774 | 0.82 | APP (0.61) | RXFP1CCR1CCR5CCR8HDAC6 | |
| SCHEMBL10000248 | 0.81 | CCR1 (0.68) | CCR1CCR5CCR8HDAC6NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102574870-B | Luminescent gold (III) compound containing bidentate ligand for organic light-emitting device and preparation method thereof | THE UNIVERSITY OF HONG KONG (CN) | 2016-05-18 | — | — | CN | claimed |
| US-8372977-B2 | Luminescent gold(III) compounds containing bidentate ligand for organic light-emitting devices and their preparation | THE UNIVERSITY OF HONG KONG (CN) | 2013-02-12 | — | — | US | claimed |
| US-20110012093-A1 | LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | THE UNIVERSITY OF HONG KONG (CN) | 2011-01-20 | — | — | US | claimed |
| WO-2011006353-A1 | LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | THE UNIVERSITY OF HONG KONG (CN) | 2011-01-20 | — | — | WO | claimed |
| US-12022832-B2 | Compounds and methods for treating nematode infections | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-07-02 | — | — | US | disclosed |
| US-11890604-B2 | Composite catalyst for carbon dioxide reduction and method of fabricating of the same | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) | 2024-02-06 | — | — | US | disclosed |
| US-20210220809-A1 | COMPOSITE CATALYST FOR CARBON DIOXIDE REDUCTION AND METHOD OF FABRICATING OF THE SAME | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) | 2021-07-22 | — | — | US | disclosed |
| WO-2020051689-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2020-03-19 | — | — | WO | disclosed |
| CN-109912567-A | A kind of biaryl pyrrole derivatives compound and preparation method thereof | 台州职业技术学院 | 2019-06-21 | — | — | CN | disclosed |
| US-20190058132-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
| CN-102574870-B | Luminescent gold (III) compound containing bidentate ligand for organic light-emitting device and preparation method thereof | THE UNIVERSITY OF HONG KONG (CN) | 2016-05-18 | — | — | CN | disclosed |
| US-20130109652-A1 | NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS | ADDEX PHARMACEUTICALS S.A. (CH) | 2013-05-02 | — | — | US | disclosed |
| EP-0428720-B1 | OPTICALLY ACTIVE COMPOUNDS AND LIQUID CRYSTAL PHASE | MERCK PATENT GMBH (DE) | 1995-03-22 | — | — | EP | disclosed |
| US-5393459-A | Optically active compounds, and a liquid-crystalline phase | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-02-28 | — | — | US | disclosed |
| US-5167859-A | Electrooptical display elements | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1992-12-01 | — | — | US | disclosed |
| EP-0283490-B1 | PROCESS FOR THE PRODUCTION OF ETHANE DERIVATIVES | MERCK PATENT GmbH (DE) | 1992-01-08 | — | — | EP | disclosed |
| EP-0428720-A1 | OPTICALLY ACTIVE COMPOUNDS AND LIQUID CRYSTAL PHASE. | MERCK PATENT GMBH (DE) | 1991-05-29 | — | — | EP | disclosed |
| WO-1990013611-A2 | OPTICALLY ACTIVE COMPOUNDS AND LIQUID CRYSTAL PHASE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-11-15 | — | — | WO | disclosed |
| EP-0283490-A1 | PROCESS FOR THE PRODUCTION OF ETHANE DERIVATIVES. | MERCK PATENT GMBH (DE) | 1988-09-28 | — | — | EP | disclosed |
| WO-1988002364-A2 | PROCESS FOR THE PRODUCTION OF ETHANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022832-B2 | Compounds and methods for treating nematode infections | HNMT, NISCH, HRH2 | RXFP1 1194/4885CCR1 1016/4885CCR5 1571/4885 |
| US-20110012093-A1 | LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | CHRM1, CHRM5, CHRM2 | RXFP1 1789/4885CCR1 741/4885CCR5 113/4885 |
| US-20130109652-A1 | NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS | GRM2, GRM1, GRIA2 | RXFP1 443/4885CCR1 2999/4885CCR5 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.